Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2024(Status and Outlook)

Global Viral Vectors and Plasmid DNA Manufacturing Market Research Report 2024(Status and Outlook)



Report Overview:

The viral vectors and plasmid DNA is used for the treatment of cancers, inherited disorders, viral infections and other diseases.

The Global Viral Vectors and Plasmid DNA Manufacturing Market Size was estimated at USD 728.28 million in 2023 and is projected to reach USD 1966.02 million by 2029, exhibiting a CAGR of 18.00% during the forecast period.

This report provides a deep insight into the global Viral Vectors and Plasmid DNA Manufacturing market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche market, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc.

The analysis helps the reader to shape the competition within the industries and strategies for the competitive environment to enhance the potential profit. Furthermore, it provides a simple framework for evaluating and accessing the position of the business organization. The report structure also focuses on the competitive landscape of the Global Viral Vectors and Plasmid DNA Manufacturing Market, this report introduces in detail the market share, market performance, product situation, operation situation, etc. of the main players, which helps the readers in the industry to identify the main competitors and deeply understand the competition pattern of the market.

In a word, this report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the Viral Vectors and Plasmid DNA Manufacturing market in any manner.

Global Viral Vectors and Plasmid DNA Manufacturing Market: Market Segmentation Analysis

The research report includes specific segments by region (country), manufacturers, Type, and Application. Market segmentation creates subsets of a market based on product type, end-user or application, Geographic, and other factors. By understanding the market segments, the decision-maker can leverage this targeting in the product, sales, and marketing strategies. Market segments can power your product development cycles by informing how you create product offerings for different segments.

Key Company

BioReliance

Cobra Biologics

Oxford BioMedica

UniQure

FinVector

MolMed

MassBiologics

Richter-Helm

FUJIFILM Diosynth Biotechnologies

Lonza

Aldevron

Eurogentec

Cell and Gene Therapy Catapult

Biovian

Thermo Fisher Scientific (Brammer Bio)

VGXI

PlasmidFactory

Market Segmentation (by Type)

Plasmid DNA

Viral Vectors

Market Segmentation (by Application)

Cancers

Inherited Disorders

Viral Infections

Others

Geographic Segmentation
  • North America (USA, Canada, Mexico)
  • Europe (Germany, UK, France, Russia, Italy, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Rest of Asia-Pacific)
  • South America (Brazil, Argentina, Columbia, Rest of South America)
  • The Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria, South Africa, Rest of MEA)
Key Benefits of This Market Research:
  • Industry drivers, restraints, and opportunities covered in the study
  • Neutral perspective on the market performance
  • Recent industry trends and developments
  • Competitive landscape & strategies of key players
  • Potential & niche segments and regions exhibiting promising growth covered
  • Historical, current, and projected market size, in terms of value
  • In-depth analysis of the Viral Vectors and Plasmid DNA Manufacturing Market
  • Overview of the regional outlook of the Viral Vectors and Plasmid DNA Manufacturing Market:
Key Reasons to Buy this Report:
  • Access to date statistics compiled by our researchers. These provide you with historical and forecast data, which is analyzed to tell you why your market is set to change
  • This enables you to anticipate market changes to remain ahead of your competitors
  • You will be able to copy data from the Excel spreadsheet straight into your marketing plans, business presentations, or other strategic documents
  • The concise analysis, clear graph, and table format will enable you to pinpoint the information you require quickly
  • Provision of market value (USD Billion) data for each segment and sub-segment
  • Indicates the region and segment that is expected to witness the fastest growth as well as to dominate the market
  • Analysis by geography highlighting the consumption of the product/service in the region as well as indicating the factors that are affecting the market within each region
  • Competitive landscape which incorporates the market ranking of the major players, along with new service/product launches, partnerships, business expansions, and acquisitions in the past five years of companies profiled
  • Extensive company profiles comprising of company overview, company insights, product benchmarking, and SWOT analysis for the major market players
  • The current as well as the future market outlook of the industry concerning recent developments which involve growth opportunities and drivers as well as challenges and restraints of both emerging as well as developed regions
  • Includes in-depth analysis of the market from various perspectives through Porter’s five forces analysis
  • Provides insight into the market through Value Chain
  • Market dynamics scenario, along with growth opportunities of the market in the years to come
  • 6-month post-sales analyst support
Customization of the Report

In case of any queries or customization requirements, please connect with our sales team, who will ensure that your requirements are met.

Note: this report may need to undergo a final check or review and this could take about 48 hours.

Chapter Outline

Chapter 1 mainly introduces the statistical scope of the report, market division standards, and market research methods.

Chapter 2 is an executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the Viral Vectors and Plasmid DNA Manufacturing Market and its likely evolution in the short to mid-term, and long term.

Chapter 3 makes a detailed analysis of the Market's Competitive Landscape of the market and provides the market share, capacity, output, price, latest development plan, merger, and acquisition information of the main manufacturers in the market.

Chapter 4 is the analysis of the whole market industrial chain, including the upstream and downstream of the industry, as well as Porter's five forces analysis.

Chapter 5 introduces the latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 6 provides the analysis of various market segments according to product types, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 7 provides the analysis of various market segments according to application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 8 provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 9 introduces the basic situation of the main companies in the market in detail, including product sales revenue, sales volume, price, gross profit margin, market share, product introduction, recent development, etc.

Chapter 10 provides a quantitative analysis of the market size and development potential of each region in the next five years.

Chapter 11 provides a quantitative analysis of the market size and development potential of each market segment (product type and application) in the next five years.

Chapter 12 is the main points and conclusions of the report.


1 Research Methodology and Statistical Scope
1.1 Market Definition and Statistical Scope of Viral Vectors and Plasmid DNA Manufacturing
1.2 Key Market Segments
1.2.1 Viral Vectors and Plasmid DNA Manufacturing Segment by Type
1.2.2 Viral Vectors and Plasmid DNA Manufacturing Segment by Application
1.3 Methodology & Sources of Information
1.3.1 Research Methodology
1.3.2 Research Process
1.3.3 Market Breakdown and Data Triangulation
1.3.4 Base Year
1.3.5 Report Assumptions & Caveats
2 Viral Vectors and Plasmid DNA Manufacturing Market Overview
2.1 Global Market Overview
2.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (M USD) Estimates and Forecasts (2019-2030)
2.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Sales Estimates and Forecasts (2019-2030)
2.2 Market Segment Executive Summary
2.3 Global Market Size by Region
3 Viral Vectors and Plasmid DNA Manufacturing Market Competitive Landscape
3.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales by Manufacturers (2019-2024)
3.2 Global Viral Vectors and Plasmid DNA Manufacturing Revenue Market Share by Manufacturers (2019-2024)
3.3 Viral Vectors and Plasmid DNA Manufacturing Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.4 Global Viral Vectors and Plasmid DNA Manufacturing Average Price by Manufacturers (2019-2024)
3.5 Manufacturers Viral Vectors and Plasmid DNA Manufacturing Sales Sites, Area Served, Product Type
3.6 Viral Vectors and Plasmid DNA Manufacturing Market Competitive Situation and Trends
3.6.1 Viral Vectors and Plasmid DNA Manufacturing Market Concentration Rate
3.6.2 Global 5 and 10 Largest Viral Vectors and Plasmid DNA Manufacturing Players Market Share by Revenue
3.6.3 Mergers & Acquisitions, Expansion
4 Viral Vectors and Plasmid DNA Manufacturing Industry Chain Analysis
4.1 Viral Vectors and Plasmid DNA Manufacturing Industry Chain Analysis
4.2 Market Overview of Key Raw Materials
4.3 Midstream Market Analysis
4.4 Downstream Customer Analysis
5 The Development and Dynamics of Viral Vectors and Plasmid DNA Manufacturing Market
5.1 Key Development Trends
5.2 Driving Factors
5.3 Market Challenges
5.4 Market Restraints
5.5 Industry News
5.5.1 New Product Developments
5.5.2 Mergers & Acquisitions
5.5.3 Expansions
5.5.4 Collaboration/Supply Contracts
5.6 Industry Policies
6 Viral Vectors and Plasmid DNA Manufacturing Market Segmentation by Type
6.1 Evaluation Matrix of Segment Market Development Potential (Type)
6.2 Global Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Type (2019-2024)
6.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Market Share by Type (2019-2024)
6.4 Global Viral Vectors and Plasmid DNA Manufacturing Price by Type (2019-2024)
7 Viral Vectors and Plasmid DNA Manufacturing Market Segmentation by Application
7.1 Evaluation Matrix of Segment Market Development Potential (Application)
7.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Sales by Application (2019-2024)
7.3 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (M USD) by Application (2019-2024)
7.4 Global Viral Vectors and Plasmid DNA Manufacturing Sales Growth Rate by Application (2019-2024)
8 Viral Vectors and Plasmid DNA Manufacturing Market Segmentation by Region
8.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales by Region
8.1.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales by Region
8.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Sales Market Share by Region
8.2 North America
8.2.1 North America Viral Vectors and Plasmid DNA Manufacturing Sales by Country
8.2.2 U.S.
8.2.3 Canada
8.2.4 Mexico
8.3 Europe
8.3.1 Europe Viral Vectors and Plasmid DNA Manufacturing Sales by Country
8.3.2 Germany
8.3.3 France
8.3.4 U.K.
8.3.5 Italy
8.3.6 Russia
8.4 Asia Pacific
8.4.1 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Sales by Region
8.4.2 China
8.4.3 Japan
8.4.4 South Korea
8.4.5 India
8.4.6 Southeast Asia
8.5 South America
8.5.1 South America Viral Vectors and Plasmid DNA Manufacturing Sales by Country
8.5.2 Brazil
8.5.3 Argentina
8.5.4 Columbia
8.6 Middle East and Africa
8.6.1 Middle East and Africa Viral Vectors and Plasmid DNA Manufacturing Sales by Region
8.6.2 Saudi Arabia
8.6.3 UAE
8.6.4 Egypt
8.6.5 Nigeria
8.6.6 South Africa
9 Key Companies Profile
9.1 BioReliance
9.1.1 BioReliance Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.1.2 BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.1.3 BioReliance Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.1.4 BioReliance Business Overview
9.1.5 BioReliance Viral Vectors and Plasmid DNA Manufacturing SWOT Analysis
9.1.6 BioReliance Recent Developments
9.2 Cobra Biologics
9.2.1 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.2.2 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.2.3 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.2.4 Cobra Biologics Business Overview
9.2.5 Cobra Biologics Viral Vectors and Plasmid DNA Manufacturing SWOT Analysis
9.2.6 Cobra Biologics Recent Developments
9.3 Oxford BioMedica
9.3.1 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.3.2 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.3.3 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.3.4 Oxford BioMedica Viral Vectors and Plasmid DNA Manufacturing SWOT Analysis
9.3.5 Oxford BioMedica Business Overview
9.3.6 Oxford BioMedica Recent Developments
9.4 UniQure
9.4.1 UniQure Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.4.2 UniQure Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.4.3 UniQure Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.4.4 UniQure Business Overview
9.4.5 UniQure Recent Developments
9.5 FinVector
9.5.1 FinVector Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.5.2 FinVector Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.5.3 FinVector Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.5.4 FinVector Business Overview
9.5.5 FinVector Recent Developments
9.6 MolMed
9.6.1 MolMed Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.6.2 MolMed Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.6.3 MolMed Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.6.4 MolMed Business Overview
9.6.5 MolMed Recent Developments
9.7 MassBiologics
9.7.1 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.7.2 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.7.3 MassBiologics Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.7.4 MassBiologics Business Overview
9.7.5 MassBiologics Recent Developments
9.8 Richter-Helm
9.8.1 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.8.2 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.8.3 Richter-Helm Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.8.4 Richter-Helm Business Overview
9.8.5 Richter-Helm Recent Developments
9.9 FUJIFILM Diosynth Biotechnologies
9.9.1 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.9.2 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.9.3 FUJIFILM Diosynth Biotechnologies Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.9.4 FUJIFILM Diosynth Biotechnologies Business Overview
9.9.5 FUJIFILM Diosynth Biotechnologies Recent Developments
9.10 Lonza
9.10.1 Lonza Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.10.2 Lonza Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.10.3 Lonza Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.10.4 Lonza Business Overview
9.10.5 Lonza Recent Developments
9.11 Aldevron
9.11.1 Aldevron Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.11.2 Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.11.3 Aldevron Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.11.4 Aldevron Business Overview
9.11.5 Aldevron Recent Developments
9.12 Eurogentec
9.12.1 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.12.2 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.12.3 Eurogentec Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.12.4 Eurogentec Business Overview
9.12.5 Eurogentec Recent Developments
9.13 Cell and Gene Therapy Catapult
9.13.1 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.13.2 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.13.3 Cell and Gene Therapy Catapult Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.13.4 Cell and Gene Therapy Catapult Business Overview
9.13.5 Cell and Gene Therapy Catapult Recent Developments
9.14 Biovian
9.14.1 Biovian Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.14.2 Biovian Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.14.3 Biovian Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.14.4 Biovian Business Overview
9.14.5 Biovian Recent Developments
9.15 Thermo Fisher Scientific (Brammer Bio)
9.15.1 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.15.2 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.15.3 Thermo Fisher Scientific (Brammer Bio) Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.15.4 Thermo Fisher Scientific (Brammer Bio) Business Overview
9.15.5 Thermo Fisher Scientific (Brammer Bio) Recent Developments
9.16 VGXI
9.16.1 VGXI Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.16.2 VGXI Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.16.3 VGXI Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.16.4 VGXI Business Overview
9.16.5 VGXI Recent Developments
9.17 PlasmidFactory
9.17.1 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Basic Information
9.17.2 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Overview
9.17.3 PlasmidFactory Viral Vectors and Plasmid DNA Manufacturing Product Market Performance
9.17.4 PlasmidFactory Business Overview
9.17.5 PlasmidFactory Recent Developments
10 Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Region
10.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast
10.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Region
10.2.1 North America Market Size Forecast by Country
10.2.2 Europe Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country
10.2.3 Asia Pacific Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Region
10.2.4 South America Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Country
10.2.5 Middle East and Africa Forecasted Consumption of Viral Vectors and Plasmid DNA Manufacturing by Country
11 Forecast Market by Type and by Application (2025-2030)
11.1 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Type (2025-2030)
11.1.1 Global Forecasted Sales of Viral Vectors and Plasmid DNA Manufacturing by Type (2025-2030)
11.1.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size Forecast by Type (2025-2030)
11.1.3 Global Forecasted Price of Viral Vectors and Plasmid DNA Manufacturing by Type (2025-2030)
11.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Forecast by Application (2025-2030)
11.2.1 Global Viral Vectors and Plasmid DNA Manufacturing Sales (K Units) Forecast by Application
11.2.2 Global Viral Vectors and Plasmid DNA Manufacturing Market Size (M USD) Forecast by Application (2025-2030)
12 Conclusion and Key Findings

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings